✦ LIBER ✦

Adjuvant adoptive immunotherapy against hepatocellular carcinoma

✍ Scribed by Tadatoshi Takayama; Teruaki Sekine; Yasushi Kondo; Tadao Kakizoe; Masatoshi Makuuchi

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 78 KB
Volume: 28
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.510280539

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant interferon for hepatocellular c

Adjuvant interferon for hepatocellular carcinoma

✍ Shuichi Okada; Toshiya Sato; Seiichiro Yamamoto 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

We read with interest the recent article by Ikeda et al. 1 and the accompanying editorial 2 on the use of interferon beta (IFN-␤) to prevent recurrent hepatocellular carcinoma (HCC) after treatment of the primary tumor. We offer comments from an oncologic perspective. The investigators repeatedly n

A phase II study of adoptive immunothera

A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma

✍ Daniel H. Palmer; Rachel S. Midgley; Noweeda Mirza; Elizabeth E. Torr; Forhad Ah 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

This is a phase II clinical trial investigating the safety and efficacy of intravenous vaccination with mature autologous dendritic cells (DCs) pulsed ex vivo with a liver tumor cell line lysate (HepG2) in patients with advanced hepatocellular carcinoma (HCC). HCC is an attractive target for immunot

Uracil-tegafur as an adjuvant for hepato

Uracil-tegafur as an adjuvant for hepatocellular carcinoma: A randomized trial

✍ Kiyoshi Hasegawa; Tadatoshi Takayama; Masayoshi Ijichi; Yutaka Matsuyama; Hirosh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB

Adjuvant oral chemotherapy to prevent re

Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma

✍ Dr M. Yamamoto; S. Arii; K. Sugahara; T. Tobe 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

Adjuvant, adoptive immunotherapy with tu

Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis

✍ Andrea Gardini; Giorgio Ercolani; Angela Riccobon; Matteo Ravaioli; Laura Ridolf 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Arsenic trioxide synergizes with B7H3-me

Arsenic trioxide synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas

✍ Liqiong Luo; Haiquan Qiao; Fanqiang Meng; Xuesong Dong; Baoguo Zhou; Hongchi Jia 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 334 KB

## Abstract Arsenic trioxide (As~2~O~3~), a valuable anticancer drug for the treatment of acute promyelocytic leukemia, may also have therapeutic potential for the treatment of solid tumors. However, its therapeutic efficacy against solid tumors is lacking even at high dosages. Other therapeutic st